[1] Yellon DM,Hausenloy DJ.Myocardial reperfusion injury. N Engl J Med, 2007, 357(11): 1121-35.
[2] Lesnefsky EJ,Chen Q,Tandler B, et al.Mitochondrial Dysfunction and Myocardial Ischemia-Reperfusion: Implications for Novel Therapies. 2017, 57(1): annurev-pharmtox-010715-103335.
[3] Kawaraguchi Y,Roth DM,Patel HH.From local to global: lipid emulsion (intralipid) makes a move. Anesthesiology, 2011, 115(2): 226-8.
[4] Motayagheni N,Phan S,Nozari A, et al.Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection. J Pharm Pharm Sci, 2017, 20(1): 329-331.
[5] Riess ML,Podgoreanu MV.Intralipid: the new magic bullet in cardioprotection? Anesthesiology, 2013, 118(5): 1237-8.
[6] Stanley WC,Dabkowski ER,Ribeiro RF, Jr., et al.Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res, 2012, 110(5): 764-76.
[7] Van de Velde M,DeWolff M,Leather HA, et al.Effects of lipids on the functional and metabolic recovery from global myocardial stunning in isolated rabbit hearts. Cardiovasc Res, 2000, 48(1): 129-37.
[8] Gosselin S,Hoegberg LC,Hoffman RS, et al.Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning(). Clin Toxicol (Phila), 2016, 54(10): 899-923.
[9] Karcioglu O.Use of lipid emulsion therapy in local anesthetic overdose. Saudi Med J, 2017, 38(10): 985-993.
[10] Neal JM,Barrington MJ,Fettiplace MR, et al.The Third American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity: Executive Summary 2017. Reg Anesth Pain Med, 2018, 43(2): 113-123.
[11] Neal JM,Woodward CM,Harrison TK.The American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2017 Version. Reg Anesth Pain Med, 2018, 43(2): 150-153.
[12] Li J,Iorga A,Sharma S, et al.Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A. Anesthesiology, 2012, 117(4): 836-46.
[13] Li J,Ruffenach G,Kararigas G, et al.Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3beta pathway. J Mol Cell Cardiol, 2017, 102: 108-116.
[14] Lou PH,Lucchinetti E,Zhang L, et al.The mechanism of Intralipid(R)-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases. PLoS One, 2014, 9(1): e87205.
[15] Rahman S,Li J,Bopassa JC, et al.Phosphorylation of GSK-3beta mediates intralipid-induced cardioprotection against ischemia/reperfusion injury. Anesthesiology, 2011, 115(2): 242-53.
[16] Umar S,Li J,Hannabass K, et al.Free Fatty Acid Receptor G-protein-coupled Receptor 40 Mediates Lipid Emulsion-induced Cardioprotection. Anesthesiology, 2018, 129(1): 154-162.
[17] Partownavid P,Umar S,Li J, et al.Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats. Crit Care Med, 2012, 40(8): 2431-7.
[18] Yu H,Li Q,Chen C, et al.Effect of intralipid on myocardial injury during valve replacement surgery with concomitant radiofrequency ablation: A randomized controlled trial. Medicine (Baltimore), 2018, 97(1): e9603.
[19] Zhou RH,Yu H,Yin XR, et al.Effect of intralipid postconditioning on myocardial injury in patients undergoing valve replacement surgery: a randomised controlled trial. Heart, 2017, 103(14): 1122-1127.
[20] Lavi S,Lavi R.Conditioning of the heart: from pharmacological interventions to local and remote protection: possible implications for clinical practice. Int J Cardiol, 2011, 146(3): 311-8.
[21] Bu XS,Zhang J,Zuo YX.Validation of the Chinese Version of the Quality of Recovery-15 Score and Its Comparison with the Post-Operative Quality Recovery Scale. Patient, 2016, 9(3): 251-9.
[22] Stark PA,Myles PS,Burke JA.Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology, 2013, 118(6): 1332-40.
[23] Ren SF,Yu H,Guo YQ, et al.Inhalation versus intravenous anesthesia for adults undergoing heart valve surgery: a systematic review and meta-analysis. Minerva Anestesiol, 2019, 85(6): 665-675.
[24] Hausenloy DJ,Yellon DM.Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis, 2009, 204(2): 334-41.
[25] Iliodromitis EK,Andreadou I,Iliodromitis K, et al.Ischemic and postischemic conditioning of the myocardium in clinical practice: challenges, expectations and obstacles. Cardiology, 2014, 129(2): 117-25.
[26] Pierce B,Bole I,Patel V, et al.Clinical Outcomes of Remote Ischemic Preconditioning Prior to Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc, 2017, 6(2).
[27] Huang Z,Zhong X,Irwin MG, et al.Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clin Sci (Lond), 2011, 121(2): 57-69.
[28] Kunst G,Klein AA.Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia, 2015, 70(4): 467-82.
[29] Qiao SG,Sun Y,Sun B, et al.Sevoflurane postconditioning protects against myocardial ischemia/reperfusion injury by restoring autophagic flux via an NO-dependent mechanism. Acta Pharmacol Sin, 2019, 40(1): 35-45.